Mos oncogene product associates with kinetochores in mammalian somatic cells and disrupts mitotic progression - PubMed (original) (raw)

Mos oncogene product associates with kinetochores in mammalian somatic cells and disrupts mitotic progression

X M Wang et al. Proc Natl Acad Sci U S A. 1994.

Abstract

The mos protooncogene has opposing effects on cell cycle progression. It is required for reinitiation of meiotic maturation and for meiotic progression through metaphase II, yet it is an active component of cytostatic factor. mos is a potent oncogene in fibroblasts, but high levels of expression are lethal. The lethality of mos gene expression in mammalian cells could be a consequence of a blockage induced by its cytostatic factor-related activity, which may appear at high dosage in mitotic cells. We have directly tested whether expression of the Mos protein can block mitosis in mammalian cells by microinjecting a fusion protein between Escherichia coli maltose-binding protein and Xenopus c-Mos into PtK1 epithelial cells and analyzing the cells by video time-lapse and immunofluorescence microscopy. Time-course analyses showed that Mos blocked mitosis by preventing progression to a normal metaphase. Chromosomes frequently failed to attain a bipolar orientation and were found near one pole. Injection of a kinase-deficient mutant Mos had no effect on mitosis, indicating that the blockage of mitotic progression required Mos kinase activity. Antitubulin immunostaining of cells blocked by Mos showed that microtubules were present but that spindle morphology was abnormal. Immunostaining for the Mos fusion protein showed that both wild-type and kinase mutant proteins localized at the kinetochores. Our results suggest that mitotic blockage by Mos may result from an action of the Mos kinase on the kinetochores, thus increasing chromosome instability and preventing normal congression.

PubMed Disclaimer

Cited by

Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos.
Vitale I, Senovilla L, Jemaà M, Michaud M, Galluzzi L, Kepp O, Nanty L, Criollo A, Rello-Varona S, Manic G, Métivier D, Vivet S, Tajeddine N, Joza N, Valent A, Castedo M, Kroemer G. Vitale I, et al. EMBO J. 2010 Apr 7;29(7):1272-84. doi: 10.1038/emboj.2010.11. Epub 2010 Feb 25. EMBO J. 2010. PMID: 20186124 Free PMC article.
Evidence of an interaction between Mos and Hsp70: a role of the Mos residue serine 3 in mediating Hsp70 association.
Liu H, Vuyyuru VB, Pham CD, Yang Y, Singh B. Liu H, et al. Oncogene. 1999 Jun 10;18(23):3461-70. doi: 10.1038/sj.onc.1202699. Oncogene. 1999. PMID: 10376524
Active MAP kinase in mitosis: localization at kinetochores and association with the motor protein CENP-E.
Zecevic M, Catling AD, Eblen ST, Renzi L, Hittle JC, Yen TJ, Gorbsky GJ, Weber MJ. Zecevic M, et al. J Cell Biol. 1998 Sep 21;142(6):1547-58. doi: 10.1083/jcb.142.6.1547. J Cell Biol. 1998. PMID: 9744883 Free PMC article.
CENP-E is an essential kinetochore motor in maturing oocytes and is masked during mos-dependent, cell cycle arrest at metaphase II.
Duesbery NS, Choi T, Brown KD, Wood KW, Resau J, Fukasawa K, Cleveland DW, Vande Woude GF. Duesbery NS, et al. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9165-70. doi: 10.1073/pnas.94.17.9165. Proc Natl Acad Sci U S A. 1997. PMID: 9256453 Free PMC article.
The casein kinase II beta subunit binds to Mos and inhibits Mos activity.
Chen M, Li D, Krebs EG, Cooper JA. Chen M, et al. Mol Cell Biol. 1997 Apr;17(4):1904-12. doi: 10.1128/MCB.17.4.1904. Mol Cell Biol. 1997. PMID: 9121438 Free PMC article.

References

1. J Exp Zool. 1971 Jun;177(2):129-45 - PubMed
1. Science. 1993 Nov 19;262(5137):1262-5 - PubMed
1. Adv Cell Biol. 1971;2:225-97 - PubMed
1. Cell. 1982 Jun;29(2):417-26 - PubMed
1. J Cell Biol. 1984 Dec;99(6):2165-74 - PubMed

Mos oncogene product associates with kinetochores in mammalian somatic cells and disrupts mitotic progression - PubMed (original) (raw)